Alpha1-Fetoprotein in Chronic Liver Disease-Reference-Cited by-同舟云学术

Alpha1-Fetoprotein in Chronic Liver Disease

Published:1974-09-05 Issue:10 Volume:291 Page:506-508
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Silver Hulbert K. B.¹,Gold Phil¹,Shuster Joseph¹,Javitt Norman B.¹,Freedman Samuel O.¹,Finlayson Niall D. C.¹

Affiliation:

1. From the Division of Clinical Immunology and Allergy and the McGill University Medical Clinic of the Montreal General Hospital, Montreal, and the New York Hospital-Cornell Medical Center, New York City (address reprint requests to Dr. Gold at the Division of Immunology and Allergy, Montreal General Hospital, 1650 Cedar Ave., Montreal, Quebec, Canada H3G 1A4).

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM197409052911006

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of patients with a high alpha-fetoprotein level but without evident recurrence on CT or MRI in surveillance after curative-intent treatment for hepatocellular carcinoma;Abdominal Radiology;2020-08-18

2. Differences in Posttransplant Hepatocellular Carcinoma Recurrence by Etiology of Liver Disease;Liver Transplantation;2019-02-28

3. Plasma level of metastasis‐associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma;Cancer Science;2016-02

4. Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma;Oncotarget;2015-04-23

5. Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy;Hepatology Research;2014-12-08